Anti-BPI is an ELISA-based, automated, in-vitro test system for the quantitative determination of IgG antibodies against bactericidal permeability-increasing protein BPI in human serum or plasma.

Antineutrophil cytoplasmic antibodies (cANCA) against bactericidal permeability-increasing protein (BPI), in addition to PR3 or MPO antibodies, are important serological markers in the diagnosis of a number of inflammatory, especially rheumatic and gastrointestinal diseases. Antibodies against BPI are primarily found in patients with cystic fibrosis and in patients with chronic inflammatory intestinal conditions like Crohn’s disease and ulcerative colitis. Anti-PR3-negative serum samples that display a typical cANCA pattern in their immunofluorescence test should be tested for BPI antibodies.


Product Number ORG 223
Tests24 Alegria® strips
Range0 - 100 U/ml
Cut-off10 U/ml
Coating bactericidal permeability-increasing protein (BPI) (human)

ORG 523   ORG 530  


Instruction for Use
Safety Data Sheet

Document Archive
Instruction for Use Revision 4. Earlier versions and additional languages can be found in the document archive.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.